Acute mountain sickness prophylaxis: A high-altitude perspective

Current Sports Medicine Reports

Volumn 12, Issue 2, 2013, Pages 110-114

  DeLellis, Stephen M ^a   Anderson, Steven E ^a   Lynch, James H ^a   Kratz, Kris ^a  

^a WOMACK ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; GINKGO BILOBA EXTRACT; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL;

ACUTE MOUNTAIN SICKNESS; ALTITUDE; ALTITUDE DISEASE; CLOTHING; FITNESS; HIGH-ALTITUDE PULMONARY EDEMA; HUMAN; LUNG EDEMA; MEDICAL LITERATURE; NUTRITION; OCCUPATIONAL DISEASE; REVIEW; SOLDIER;

ACETAZOLAMIDE; ACUTE DISEASE; ALTITUDE; ALTITUDE SICKNESS; HUMANS; MOUNTAINEERING; OXIMETRY;

EID: 84877897621     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1249/JSR.0b013e3182874d0f     Document Type: Review

References (26)

1. Anglim AM, Boyd DW. Regimented techniques facilitate a rapid ascent to very high altitude: a controlled study. J. Spec. Oper. Med. 2012; 12:48-7.
2. Basnyat B, Murdoch DR. High altitude illness. Lancet. 2003; 361:1967-74.
3. Bates MG, Thompson AA, Baillie JK, et al. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial. High Alt. Med. Biol. 2011; 12:207-14.
4. Carlsten C, Swenson ER, Ruoss S. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 ft. (3630 m). High Alt. Med. Biol. 2004; 5:33-9.
5. Chow T, Browne V, Heileson HL, et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch. Intern. Med. 2005; 165:296-301.
6. DeLellis SM. Acetazolamide or not, prior to ascent. J. Spec. Oper. Med. 2010; 10:38-40.
7. Eide RP, Asplund CA. Altitude illness: update on prevention and treatment. Curr. Sports Med. Rep. 2012; 3:124-30.
8. Fagenholz PJ, Gutman JA, Murray AF, et al. Treatment of high altitude pulmonary edema at 4240 m in Nepal. High Alt. Med. Biol. 2007; 8:139-46.
9. Faoro V, Lamotte M, Deboeck G, et al. Effects of sildenafil on exercise capacity in hypoxic normal subjects. High Alt. Med. Biol. 2007; 8:155-63.
10. Fiore DC, Hall S, Shoja P. Altitude illness: risk factors, prevention, presentation, and treatment. Am. Fam. Physician. 2010; 82:1103-10.
11. Hackett PH, Shlim DR. Centers for Disease Control and Prevention, 2012 Yellow Book - Travelers' Health; Chapter 2 - Altitude Illness. Available at http://wwwnc.cdc.gov/travel/page/yellowbook-2012-home.htm, last referenced 1 June 2012.
12. Jacobs KA, Kressler J, Stoutenberg M, et al. Sildenafil has little influence on cardiovascular hemodynamics or 6-km time trial performance in trained men and women at simulated high altitude. High Alt. Med. Biol. 2011; 12:215-22.
13. Kenrick PA. Altitude sickness: Ginkgo biloba does not prevent altitude sickness. BJM. 2003; 327:106.
14. Lalande S, Snyder EM, Olson TP, et al. The effects of sildenafil and acetazolamide on breathing efficiency and ventilator control during hypoxic exercise. Eur. J. Appl. Physiol. 2009; 106:509-15.
15. Leadbetter G, Keyes LE, Maakestad KM, et al. Ginkgo biloba does - and does not - prevent acute mountain sickness. Wilderness Environ. Med. 2009; 20:66-71.
16. Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ. Med. 2010; 21:146-55.
17. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann. Intern. Med. 2006; 145:497-506.
18. Midla GS. Lessons learned: operation anaconda. Mil. Med. 2004; 169:810-13.
19. Moraga FA, Flores A, Serra J, et al. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile. Wilderness Environ. Med. 2007; 18:251-7.
20. Pesce C, Leal C, Pinto H, et al. Determinants of acute mountain sickness and success on mount Aconcagua (6962 m). High Alt. Med. Biol. 2005; 6:158-66.
21. Rodway GW, Muza SR. Fighting in thin air: operational wilderness medicine in high Asia. Wilderness Environ. Med. 2011; 22:297-303.
22. Seupaul RA, Welch JL, Malka ST, Emmett TW. Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review. Ann. Emerg. Med. 2012; 59:307-17.
23. Sutton JR, Coates G, Houston CS. Hypoxia and Mountain Medicine: Proceedings of the 7th International Hypoxia Symposium Held at Lake Louise, Canada, February 1991. New York, NY: Pergamon Press; 1992.
24. The Lake Louise Criteria for the diagnosis of altitude illness were adopted at the 1991 International Hypoxia Symposium, held at Lake Louise in Alberta, Canada.
25. van Patot MC, Keyes LE, Leadbetter G, Hackett PH. Ginkgo biloba for prevention of acute mountain sickness: does it work? High Alt. Med. Biol. 2009; 10:33-43.
26. van Patot MC, Leadbetter G, Keyes LE, et al. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt. Med. Biol. 2008; 9:289-93.